Can a gentle electric patch ease C-Section recovery?
NCT ID NCT07777939
First seen Aug 20, 2026 · Last updated Aug 25, 2026 · Updated 3 times
Summary
This trial tests whether wearing a small electrical stimulation device (TENS) for the first 24 hours after a cesarean delivery can improve recovery and reduce pain. Women who have a C-section under spinal anesthesia will be randomly assigned to receive either standard pain medication plus the TENS device or standard pain medication alone. The study measures recovery quality and pain levels to see if the device adds meaningful benefit.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcutaneous electrical nerve stimulation (TENS) device
- What this could lead to
- If effective, TENS could become a standard, drug-free addition to post-cesarean pain management, improving recovery and reducing reliance on opioids.
- What could go wrong
- This is a single trial with a specific population; results may not apply broadly. TENS may not provide significant pain relief, and some women may find the device uncomfortable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 196 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18-45 years. * Undergoing CD under spinal anesthesia. * Hemodynamically stable postoperatively. * Able to provide informed consent. Exclusion Criteria: * Undergoing CD under epidural or general anesthesia. * Skin lesions or infection at electrode placement sites. * Pacemaker or implanted electrical devices. * Neurological disorders affecting pain perception. * Chronic opioid use or chronic pain disorders. * Allergy or other contraindication to opioids, nonsteroidal antiinflammatory drugs, or acetaminophen use. * Adhesive allergy. * Midline vertical skin incision (in the current or previous cesarean). * Intraoperative sterilization. * Cesarean hysterectomy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Post cesarean pain management are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Holy Family Hospital
Nazareth, Israel